Fundraising Fox
/Companies
Sign in

Good Therapeutics

acquired by Roche

Seattle, US · Founded 2016 · Delaware corporation · 5 known investors

Find your way into Good Therapeutics

Sign up to see every warm intro you have to Good Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Good Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Portfolio company acquired by Roche.

Biotech

Founders & leadership

Good Therapeutics was founded in 2016 by John Mulligan.

JMJohn Mulligan
John MulliganFounderJohn Mulligan held early-stage roles at multiple drug discovery and synthetic biology companies, including Darwin Molecular where he contributed to the discovery of an osteoporosis drug target using human genetics, and Glycostasis where he developed a glucose-responsive insulin technology. He served as CEO of Good Therapeutics, which was acquired by Roche in 2022, and currently leads Bonum Therapeutics and co-founded Nagoon Therapeutics, both focused on therapeutic protein engineering.
MM
Mitchell MutzNamed on SEC filing
NW
Nicholas WalrodNamed on SEC filing

Board

JMJohn McKearn
John McKearnBoard directorSenior Advisor at RiverVest Venture Partners, focused on early-stage biotech
KH
Karl HandelsmanBoard director

Investors · 5

RiverVest Venture Partnerslisted by RiverVest Venture PartnersSt. Louis · $500K – $3M

How we know: RiverVest Venture Partners's portfolio page · a partner's Signal profile · board seat on SEC Form D · Not right? Tell us

3x5 PartnersreportedPortland

How we know: open dataset · 5k.vc investor directory · Not right? Tell us

Codon CapitalreportedSan Francisco

How we know: a partner's Signal profile · Not right? Tell us

Roche Venture FundreportedBasel · $648K – $3.2M

How we know: a partner's Signal profile · funding news · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$31.1M disclosed across 2 of 4 rounds · 2018–2021

▶$8.8MraisedDec 2021 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Karl HandelsmanDirector
  • John MulliganExecutive Officer, Director, Promoter
  • Nicholas WalrodDirector
  • John McKearnDirector
  • Diane HollenbaughExecutive Officer
  • Monique SchiersingDirector
  • Neela PatelExecutive Officer
Offering amount
$26.4M
Amount sold
$8.8M
First sale
Dec 2021
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$22.3MraisedMay 2020 · 6 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Mitchell MutzDirector
  • John McKearnDirector
  • Nicholas WalrodDirector
  • John MulliganExecutive Officer, Director, Promoter
  • Karl HandelsmanDirector
Offering amount
$22.3M
Amount sold
$22.3M
First sale
Nov 2018
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Roche to acquire Good Therapeutics' lead drug program for $250M, plus milestone payments – GeekWiregeekwire.com · Sep 2022Good Therapeutics raises $11M to develop 'context dependent' protein drugs – GeekWiregeekwire.com · May 2020

Frequently asked questions

What does Good Therapeutics do?
Portfolio company acquired by Roche.
Who founded Good Therapeutics?
Good Therapeutics was founded by John Mulligan in 2016.
Who are Good Therapeutics's investors?
Good Therapeutics's investors include Digitalis Ventures, RiverVest Venture Partners, 3x5 Partners, Codon Capital, Roche Venture Fund.
How much funding has Good Therapeutics raised?
Good Therapeutics has disclosed $31.1M raised across 2 of its 4 known rounds.
Who acquired Good Therapeutics?
Good Therapeutics was acquired by Roche.
Where is Good Therapeutics headquartered?
Good Therapeutics is headquartered in Seattle, US.